MedTrace Logo

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

NCT00667173 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2012-02-20

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.

Conditions

  • Rosacea

Interventions

DRUG

IDP-115

Topical application for 12 weeks

DRUG

Vehicle

Topical application for 12 weeks

DRUG

Vehicle

Topical application for 12 weeks

Sponsors & Collaborators

  • Dow Pharmaceutical Sciences

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00667173 on ClinicalTrials.gov